Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Politics, Policy & Law

FDA thaws communications but sends mixed message on ‘gender ideology’

Agency has resumed release of routine regulatory announcements and complied with a court order to restore some webpages

By Steve Usdin, Washington Editor
February 14, 2025 10:36 PM UTC

FDA’s freeze on public communications is easing. The thaw does not extend to the agency’s interpretation of the Trump administration’s campaign against “gender ideology.”

The clearest sign of this thaw came Friday, when FDA announced the qualification of a new surrogate endpoint to speed the development and approval of treatments for alcohol use disorder. FDA finalized the decision on Jan. 24 but held back on announcing the qualification during the communications freeze. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

U.S. Food and Drug Administration (FDA)